Learning from oncocytic tumors: Why choose inefficient mitochondria?
Authors:
- Giuseppe GasparreGGGiuseppe Gasparre
- Giovanni RomeoGRGiovanni Romeo
- Michela RugoloMichela Rugolo
- Anna Maria PorcelliAPAnna Maria Porcelli
- 1 June 2011
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Vol. 1807 (6) , 633-642
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana Ricerca sul Cancro (8810)
- Italian Ministry of University and Research (PRIN 2008SW44CS)
This publication has 94 references indexed in Scilit:
- Mitochondrial Dysfunction Contributes to Oncogene-Induced SenescenceMolecular and Cellular Biology, 2009
- SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromesJournal of Internal Medicine, 2009
- Lack of complex I is associated with oncocytic thyroid tumoursBritish Journal of Cancer, 2009
- A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosisHuman Molecular Genetics, 2009
- ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell MetastasisScience, 2008
- Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumorsProceedings of the National Academy of Sciences, 2007
- PGC-1α/β upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutationsHuman Molecular Genetics, 2007
- An enhanced MITOMAP with a global mtDNA mutational phylogenyNucleic Acids Research, 2006
- Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomasBritish Journal of Cancer, 2006
- Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signalingProceedings of the National Academy of Sciences, 2006